Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (81)
- Legislation (15)
- Committees and advisory bodies (12)
- Labelling and packaging (7)
- Manufacturing (7)
- Safety monitoring and information (5)
- Advertising (3)
- Fees and payments (3)
- Import and export (3)
- Shortages and supply disruptions (3)
- Sunscreens (3)
- Medicinal cannabis hub (2)
- Clinical trials (1)
- Compliance and enforcement (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
25 result(s) found, displaying 1 to 25
-
ConsultationWe are seeking feedback on the current usage of paper information included with injectable medicines.
-
ConsultationWe are seeking feedback on whether we should adopt 3 international scientific guidelines.
-
ConsultationWe are seeking feedback on whether 19 international scientific guidelines should be adopted.
-
ConsultationWe are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.
-
ConsultationThe TGA sought feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.
-
ConsultationThe TGA is seeking feedback from interested parties on the proposed changes to replace the sunsetting TGO 70C with a new instrument
-
Consultation: Proposed exposure model for assessing the safety of sunscreen ingredients in Australia
ConsultationHave your say on best way to estimate sunscreen use in Australia. Your feedback will be used to calculate the safe concentration of sunscreen ingredients. -
ConsultationHave your say about proposed changes to address 3 medicine safety matters needing action, before we review labelling rules more broadly.
-
ConsultationWe are consulting to better understand the nature, extent and urgency of problems with the supply of medicines, including shortages and discontinuations of medicines in Australia.
-
ConsultationWe are seeking feedback on whether certain international scientific guidelines should be adopted.
-
ConsultationWe sought feedback on the proposed new ‘Guidelines for the Quality of Listed Probiotic Medicines’.
-
ConsultationThe TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023
-
ConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted.
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on whether or not certain international scientific guidelines should be adopted.
-
ConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted. Closing date: 20 February 2022
-
ConsultationThe outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published
-
ConsultationView the outcomes of public consultation on building a more robust medicine supply
-
ConsultationThe closing date has been extended until 30 March 2021.
-
ConsultationTGA is seeking feedback on a proposal to streamline how information about certain therapeutic goods formulations is entered into TGA electronic systems when seeking market approval. Closing date: 24 February 2021
-
ConsultationConsultation: Permissible ingredients annual changes 2020-21
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on proposed requirements for serialisation and the use of data matrix codes on the labels of certain medicines in the Australian supply chain.
-
ConsultationConsultation on proposed adoption or non-adoption of EU and ICH guidelines. Closing date: 7 Feb 2020
-
ConsultationThese proposed ingredient changes have been reviewed and categorised as being of low-negligible risk. Closing date: 11 October 2019
-
ConsultationThe TGA is seeking comments on the proposed guidance for the use of Boxed Warnings for prescription medicines. Closing date: 31 August 2018
-
ConsultationConsultation on options for a regulatory response to the potential misuse of prescribed Schedule 8 opioids in Australia